bluebird bio Statistics

Total Valuation

bluebird bio has a market cap or net worth of GBP 35.88 million. The enterprise value is 137.79 million.

Market Cap	35.88M
Enterprise Value	137.79M

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	9.74M
Shares Outstanding	n/a
Shares Change (YoY)	+46.73%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.45
PB Ratio	-0.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.89
EV / Sales	1.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.77

Financial Position

The company has a current ratio of 0.55

Current Ratio	0.55
Quick Ratio	0.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.94
Interest Coverage	-8.97

Financial Efficiency

Return on equity (ROE) is -546.54% and return on invested capital (ROIC) is -37.22%.

Return on Equity (ROE)	-546.54%
Return on Assets (ROA)	-28.37%
Return on Invested Capital (ROIC)	-37.22%
Return on Capital Employed (ROCE)	1,100.96%
Revenue Per Employee	324,408
Profits Per Employee	-624,123
Employee Count	248
Asset Turnover	0.22
Inventory Turnover	1.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-87.09%
50-Day Moving Average	7.90
200-Day Moving Average	13.91
Relative Strength Index (RSI)	25.86
Average Volume (20 Days)	2,235

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.49

Income Statement

In the last 12 months, bluebird bio had revenue of GBP 80.45 million and -154.78 million in losses. Loss per share was -15.94.

Revenue	80.45M
Gross Profit	21.82M
Operating Income	-162.94M
Pretax Income	-154.65M
Net Income	-154.78M
EBITDA	-115.48M
EBIT	-162.94M
Loss Per Share	-15.94

Full Income Statement

Balance Sheet

The company has 60.95 million in cash and 167.95 million in debt, giving a net cash position of -107.01 million.

Cash & Cash Equivalents	60.95M
Total Debt	167.95M
Net Cash	-107.01M
Net Cash Per Share	n/a
Equity (Book Value)	-44.79M
Book Value Per Share	-4.57
Working Capital	-108.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -177.08 million and capital expenditures -1.30 million, giving a free cash flow of -178.38 million.

Operating Cash Flow	-177.08M
Capital Expenditures	-1.30M
Free Cash Flow	-178.38M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.12%, with operating and profit margins of -202.52% and -192.39%.

Gross Margin	27.12%
Operating Margin	-202.52%
Pretax Margin	-192.22%
Profit Margin	-192.39%
EBITDA Margin	-143.53%
EBIT Margin	-202.52%
FCF Margin	n/a

Dividends & Yields

bluebird bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.73%
Shareholder Yield	n/a
Earnings Yield	-431.43%
FCF Yield	-497.21%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 13, 2024. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 13, 2024
Split Type	Reverse
Split Ratio	0.05

Scores

bluebird bio has an Altman Z-Score of -23.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-23.78
Piotroski F-Score	n/a